News

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.
Three patients with a muscle-wasting disease died from liver failure after taking the therapy, Ele­vidys, or a similar ...
The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.
Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...